Prot #GO40558: A Phase II, Open-Label, Multicenter, Randomized Study Of The Efficacy And Safety Of RO7198457 In Combination With Pembrolizumab Versus Pembrolizumab In Patients With Previously Untreated Advanced Melanoma

Project: Research project

Project Details

StatusActive
Effective start/end date9/11/199/11/22

Funding

  • Covance Inc. (Prot #GO40558)
  • Genentech, Inc. (Prot #GO40558)